NCT01428934View on ClinicalTrials.gov

Improving Intermediate Risk Management. MARK Study

CompletedOBSERVATIONAL
Enrollment

2,495

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2016

Conditions
Myocardial InfarctionAngina PectorisStrokePeripheral Arterial Disease
Trial Locations (1)

17003

Unidad de Investigación en Atención Primaria de Girona, IDIAP Jordi Gol, Institut Català de la Salut, Girona

All Listed Sponsors
collaborator

Preventive Services and Health Promotion Research Network

OTHER

lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

NCT01428934 - Improving Intermediate Risk Management. MARK Study | Biotech Hunter | Biotech Hunter